🧭Clinical Trial Compass

Am I eligible?Pricing About

Clinical Trial Compass

Data sourced from ClinicalTrials.gov and OpenFDA. For informational purposes only. Always consult your healthcare provider.

Not medical advice.

Healthy Volunteer Study (NCT07270783) | Clinical Trial Compass

Active — Not RecruitingPhase 1

Healthy Volunteer Study

United States36 participantsStarted 2025-12-04

Plain-language summary

Double Blinded Healthy Volunteer study evaluating D-2570 against placebo in various doses.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy volunteer subjects meeting eligibility criteria Exclusion Criteria: * Subjects with ongoing or history of disease or co-morbidities as assessed by Principal Investigator which would make them ineligible for the study * Subjects with a history of drug and alcohol abuse * Subjects taking medications, over the counter or herbal remedies

What they're measuring

1

Incidence of adverse events

Timeframe: From Informed Consent through study completion, an average of 48 days

2

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days

3

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days

4

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days

5

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days

6

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days.

7

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days

8

Result of Pharmacokinetic endpoint

Trial details

NCT IDNCT07270783

SponsorInventisBio Co., Ltd

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Healthy Volunteer trials

Timeframe: From Randomization through study completion, an average of 20 days

9

Result of Pharmacokinetic endpoint

Timeframe: From Randomization through study completion, an average of 20 days